Using CRISPR interference (CRISPRi) Viability Screens to Map

Using CRISPR interference (CRISPRi) Viability Screens to Map Long Noncoding RNA Dependencies in Tumor Cells, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) April 03, 2022 -- A fundamental question in cancer biology is to define the key oncogenic features of long non-protein coding RNAs

Related Keywords

United Kingdom , Eugenio Morelli , Paul Diehl , Honeycomb Worldwide Inc , Cellecta Inc , Dana Farber Cancer Institute Harvard Medical School , Dana Farber Cancer Institute , Harvard Medical School , Chief Operating Officer , Viability Screens , Map Long Noncoding , Life Science , Press Release ,